Trade Mark Infringement, Spurious Drugs or Misbranded Drugs?
by Murali Neelakantan†
Cite as: 2022 SCC OnLine Blog Exp 28
Manufacture
Complete dismantling and further re-making amounts to manufacture; appellant was not required to reverse Cenvat credit under Section 16(2) of Central Excise Rules: CESTAT
Customs, Excise & Service Tax Appellate Tribunal (CESTAT): A Division Bench comprising of Ashok Jindal Member (Judicial) and Anil G. Shakkarwar Member